- News & Analysis
Page 778
Celgene sees billion dollar potential at Juno
Biotech giant Celgene invests $1bn into immunotherapy leader Juno Therapeutics.
Jul 1, 2015Allscripts issues $200m cheque to NantHealth
Allscripts purchased a 10% stake in the cloud-based healthcare IT company, following on from a strategic partnership formed by the two in March this year.
Jul 1, 2015Novo exits Spinifex in $200m Novartis acquisition
Queensland's Spinifex sells to Novartis for $200m.
Jun 30, 2015Parkwalk regenerates Orthox
Oxford life sciences spin-out Orthox secures round from Isis Fund and Parkwalk.
Jun 30, 2015NantCell acquires VivaBioCell
NantCell, an immuno-oncology subsidiary of conglomerate NantWorks, has acquired biotechnology company VivaBioCell, providing Generali with an exit.
Jun 29, 2015Novo exits Spinifex in $200m Novartis acquisition
Spinifex had raised just over $60m in funding, including $45m in a Novo-backed series C round in April 2014.
Jun 29, 2015MIT spin-out squeezes in $5m
MIT spin-out SQZ Biotech raises $5m in series A to develop cell squeezing technology.
Jun 29, 2015Catabasis prices $60m IPO
The biotechnology company previously raised more than $100m from investors including Medimmune, a subsidiary of pharmaceutical company AstraZeneca.
Jun 29, 2015About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin